Homecgrp

  • Teva Announces AJOVY™ (fremanezumab) approval in the US market

    • September 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ICER report gives thumbs up to Aimovig for Chronic Migraine patients

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Prophylactic Migraine drug Atogepant displays positive efficacy and safety results in Ph 2b/3 trials

    • June 13, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Aimovig, first aCGRP drug for preventive treatment of Migraine

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more